SanBio Announces the Completion of Enrollment of Its Clinical Trial of Cell Therapy for Chronic Stroke Deficits.（55KB）
SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury.（118KB）
SanBio Announces Successful Enrollment of the Second Cohort of Patients in its Clinical Trial of Stem Cell Therapy for Chronic Stroke.（255KB）
Researchers Testing Stem Cells As Treatment For Stroke Recovery.（117KB）
Researchers at UPMC, Stanford Test Stem Cells to Enhance Stroke Recovery.（85KB）
SanBio Announces Enrollment of First Cohort of Patients in its Clinical Trial of Stem Cell Therapy for Chronic Stroke.（239KB）
AWARD – Bioscience: SanBio Creates Better Odds for Stroke Recovery.（133KB）
SanBio Announces First Patient Treated at Stanford With Novel Cell Therapy, SB623, in Clinical Trial of Stable Stroke Patients.（9KB）
SanBio Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center.（9KB）
Stanford and SanBio announce a clinical trial of cell therapy for stroke disability.（52KB）
